PubRank

Satoru Imura

Author PubWeight™ 72.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The changes of the medial right lobe, transplanted with left lobe liver graft from living donors. Transplantation 2009 1.42
2 Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas 2008 1.33
3 Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. J Gastroenterol 2009 1.10
4 Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients. Pancreas 2006 1.05
5 CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma. J Gastroenterol 2010 1.04
6 Current concept of small-for-size grafts in living donor liver transplantation. Surg Today 2008 1.02
7 Significance of sonic hedgehog signaling after massive hepatectomy in a rat. Surg Today 2012 0.98
8 Human adipose-derived stem cells: potential clinical applications in surgery. Surg Today 2010 0.98
9 Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2011 0.98
10 Risk Model for Distal Gastrectomy When Treating Gastric Cancer on the Basis of Data From 33,917 Japanese Patients Collected Using a Nationwide Web-based Data Entry System. Ann Surg 2015 0.97
11 Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy. Ann Surg Oncol 2014 0.95
12 Real time elastography for noninvasive diagnosis of liver fibrosis. J Hepatobiliary Pancreat Surg 2009 0.95
13 Hepatic screlosed hemangioma which was misdiagnosed as metastasis of gastric cancer: report of a case. J Med Invest 2012 0.94
14 Influence of Dai-kenchu-to (DKT) on human portal blood flow. Hepatogastroenterology 2008 0.94
15 Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2014 0.93
16 Oxaliplatin-related sinusoidal obstruction syndrome mimicking metastatic liver tumors. Hepatol Res 2013 0.93
17 High expression of cancer stem cell markers in cholangiolocellular carcinoma. Surg Today 2012 0.93
18 Hepatocellular carcinoma with spontaneous regression: report of the rare case. Hepatogastroenterology 2008 0.92
19 Cholangiolocellular carcinoma containing hepatocellular carcinoma and cholangiocellular carcinoma, extremely rare tumor of the liver:a case report. J Med Invest 2008 0.91
20 Laparoscopic hepatic resection for metastatic liver tumor of colorectal cancer: comparative analysis of short- and long-term results. Surg Endosc 2013 0.90
21 The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression. Exp Cell Res 2012 0.89
22 Specific miRNA expression profiles of non-tumor liver tissue predict a risk for recurrence of hepatocellular carcinoma. Hepatol Res 2013 0.89
23 Outcome of hepatectomy in super-elderly patients with hepatocellular carcinoma. Hepatol Res 2012 0.89
24 A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis E in Liver Transplant Recipients in Japan. EBioMedicine 2015 0.89
25 Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines. J Med Invest 2011 0.88
26 Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve. J Gastroenterol 2011 0.87
27 Hepatocellular carcinoma with massive bile duct tumor thrombus: report of a long-term survival. Hepatogastroenterology 2009 0.87
28 Beneficial effects of splenectomy on massive hepatectomy model in rats. Hepatol Res 2009 0.87
29 Efficacy of vessel sealing system for major Glisson bundles and major bile ducts. J Hepatobiliary Pancreat Surg 2008 0.87
30 Role of thymidine phosphorylase and orotate phosphoribosyltransferase mRNA expression and its ratio to dihydropyrimidine dehydrogenase in the prognosis and clinicopathological features of patients with pancreatic cancer. Int J Clin Oncol 2007 0.87
31 Mucoepidermoid carcinoma of the liver: report of a rare case and review of the literature. Hepatol Res 2008 0.86
32 Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today 2011 0.86
33 Sclerosed hemangioma of the liver: Report of a case and review of the literature. Hepatol Res 2007 0.86
34 Surgical results of pancreatoduodenectomy in elderly patients. Surg Today 2012 0.85
35 Recent role of splenectomy in chronic hepatic disorders. Hepatol Res 2008 0.85
36 Argon gas embolism in the application of laparoscopic microwave coagulation therapy. J Hepatobiliary Pancreat Surg 2009 0.85
37 Serum evaluation of soluble interferon-alpha/beta receptor and high-sensitivity C-reactive protein for diagnosis of the patients with gastrointestinal and hepatobiliary-pancreatic cancer. Cytokine 2009 0.84
38 Hypomethylation of long interspersed nuclear element-1 (LINE-1) is associated with poor prognosis via activation of c-MET in hepatocellular carcinoma. Ann Surg Oncol 2014 0.84
39 The beneficial effects of Kampo medicine Dai-ken-chu-to after hepatic resection: a prospective randomized control study. Hepatogastroenterology 2012 0.84
40 Prediction of recurrence of hepatocellular carcinoma after curative hepatectomy using preoperative Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein. Hepatol Res 2012 0.84
41 Hepatic epithelioid angiomyolipoma with arterioportal venous shunting mimicking hepatocellular carcinoma: report of a case. J Med Invest 2013 0.83
42 Expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) in patients with the gallbladder carcinoma. Int J Clin Oncol 2010 0.83
43 Loss of FBXW7 expression is associated with poor prognosis in intrahepatic cholangiocarcinoma. Hepatol Res 2014 0.82
44 Mass-forming pancreatitis with positive fluoro-2-deoxy-D: -glucose positron emission tomography and positive diffusion-weighted imaging-magnetic resonance imaging: Report of a case. Surg Today 2009 0.81
45 Role of histone deacetylase expression in intrahepatic cholangiocarcinoma. Surgery 2011 0.81
46 Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells. Int J Clin Oncol 2011 0.81
47 Senescence-related genes possibly responsible for poor liver regeneration after hepatectomy in elderly patients. J Gastroenterol Hepatol 2014 0.80
48 Significance of dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expressions in hepatocellular carcinoma. Hepatol Res 2008 0.80
49 Effect of long-term late-evening snack on health-related quality of life in cirrhotic patients. Hepatol Res 2010 0.80
50 Beneficial use of the round ligament as a patch graft for vena cava reconstruction. J Hepatobiliary Pancreat Surg 2008 0.80
51 Comparison of measured and predicted energy expenditure in patients with liver cirrhosis. Asia Pac J Clin Nutr 2014 0.80
52 Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in gallbladder carcinoma. Surg Today 2012 0.80
53 Pharmacokinetics of cyclosporine A after massive hepatectomy: a hint for small-for-size graft in living donor liver transplantation. Dig Dis Sci 2007 0.79
54 Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha. Cancer Chemother Pharmacol 2006 0.79
55 The role of Aurora B expression in non-tumor liver tissues of patients with hepatocellular carcinoma. Int J Clin Oncol 2013 0.79
56 Regulatory T cells in the blood: a new marker of surgical stress. Surg Today 2013 0.79
57 The timing of liver transplantation after primary hepatectomy for hepatocellular carcinoma: a special reference to recurrence pattern and Milan criteria. Transplantation 2008 0.79
58 Beneficial effects of hyperbaric oxygen pretreatment on massive hepatectomy model in rats. Transplantation 2007 0.79
59 High STAT4 expression is a better prognostic indicator in patients with hepatocellular carcinoma after hepatectomy. Ann Surg Oncol 2014 0.79
60 A simple formula to calculate the liver drainage volume of the accessory right hepatic vein using its diameter alone. Surgery 2009 0.79
61 Changes of immunological parameters with administration of Japanese Kampo medicine (Juzen-Taihoto/TJ-48) in patients with advanced pancreatic cancer. Int J Clin Oncol 2013 0.79
62 Beneficial effects of follistatin in hepatic ischemia-reperfusion injuries in rats. Dig Dis Sci 2010 0.78
63 Homing effect of adipose-derived stem cells to the injured liver: the shift of stromal cell-derived factor 1 expressions. J Hepatobiliary Pancreat Sci 2014 0.78
64 Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: a special reference to gene-expression microarray analysis. Oncol Rep 2011 0.78
65 The protective effect of adipose-derived stem cells against liver injury by trophic molecules. J Surg Res 2012 0.78
66 Pre- and postoperative nutritional assessment and health-related quality of life in recipients of living donor liver transplantation. Hepatol Res 2013 0.78
67 Effects of pegylated interferon α2b on metastasis of hepatocellular carcinoma. J Surg Res 2010 0.78
68 Transient portocaval shunt for a small-for-size graft in living donor liver transplantation. Liver Transpl 2008 0.78
69 Hydrolyzed whey peptide-based diet ameliorates hepatic ischemia-reperfusion injury in the rat nonalcoholic fatty liver. Surg Today 2014 0.78
70 Indoleamine 2,3-dioxygenase affects the aggressiveness of intraductal papillary mucinous neoplasms through Foxp3+CD4+CD25+ T cells in peripheral blood. Pancreas 2013 0.78
71 Clinicopathological characteristics of patients with non-B non-C hepatocellular carcinoma: a special reference to metabolic syndrome. Hepatogastroenterology 2014 0.78
72 Role of tumor angiogenesis in gallbladder carcinoma: with special reference to thymidine phosphorylase. Int J Clin Oncol 2008 0.78
73 Bevacizumab improves splenomegaly and decreases production of hyaluronic acid after L-OHP based chemotherapy. Anticancer Res 2014 0.78
74 Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma. Int J Clin Oncol 2012 0.78
75 Living donor liver transplantation using a left hepatic graft from a donor with a history of gastric cancer operation. Transpl Int 2009 0.78
76 Effects of splenectomy on hepatic gene expression profiles after massive hepatectomy in rats. J Gastroenterol Hepatol 2013 0.77
77 Effect of Twist and Bmi1 on intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol Hepatol 2014 0.77
78 Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol Hepatol 2015 0.77
79 Beneficial effects of green tea catechin on massive hepatectomy model in rats. J Gastroenterol 2013 0.77
80 Beneficial effects of enteral nutrition containing with hydrolyzed whey peptide on warm ischemia/reperfusion injury in the rat liver. Hepatol Res 2013 0.77
81 Hypoxia inducible factor expression in intrahepatic cholangiocarcinoma. Hepatogastroenterology 2011 0.77
82 Beneficial effects of Kampo medicine Inchin-ko-to on liver function and regeneration after hepatectomy in rats. Hepatol Res 2008 0.77
83 Effects of a whey peptide-based enteral formula diet on liver dysfunction following living donor liver transplantation. Surg Today 2012 0.76
84 Somatostatin and propranolol for the treatment of small-for-size syndrome after liver transplantation. J Hepatobiliary Pancreat Surg 2008 0.76
85 Living-donor liver transplantation: present status and future perspective. J Med Invest 2005 0.76
86 Huge focal nodular hyperplasia difficult to distinguish from well-differentiated hepatocellular carcinoma. Hepatol Res 2012 0.76
87 [Pathophysiology and strategy for small-for-size graft syndrome after living-donor liver transplantation]. Nihon Geka Gakkai Zasshi 2004 0.75
88 Advanced application of a vessel sealing system for major hepatic resections. Surg Endosc 2007 0.75
89 Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma. Surg Today 2011 0.75
90 Treatment of rapid weight loss in a donor with hepatic steatosis in living donor liver transplantation: a case report. Hepatogastroenterology 2012 0.75
91 [TIPS AND PITFALLS IN THE LAPAROSCOPIC HEPATIC RESECTION]. Nihon Geka Gakkai Zasshi 2016 0.75
92 Carcinogenic Potential of Biliary Epithelium of Congenital Choledochal Cyst Model in Rats: A Special Reference to HDAC Expression. Hepatogastroenterology 2014 0.75
93 Role of dihydropyrimidine dehydrogenase and thymidylate synthase expression in immunohistochemistry of intrahepatic cholangiocarcinoma. Hepatol Res 2010 0.75
94 Atypically large well-differentiated hepatocellular carcinoma with extensive fatty metamorphosis: report of a case. J Med Invest 2013 0.75
95 Complication of portal vein thrombosis after right hemihepatectomy in a patient lacking the portal vein bifurcation. J Med Invest 2016 0.75
96 Clinical role of Foxp3+ regulatory T cell in Living donor related liver transplantation for prediction of life-threatening complications. J Med Invest 2015 0.75
97 Beneficial effects of fluvastatin on liver microcirculation and regeneration after massive hepatectomy in rats. Dig Dis Sci 2008 0.75
98 Benefits of simultaneous laparoscopic resection of primary colorectal cancer and liver metastases. Asian J Endosc Surg 2013 0.75
99 Hand-assisted laparoscopic splenectomy for a huge splenic vascular lesion with aneurysms in a patient with impending Kasabach-Merritt syndrome-like phenomenon. J Med Invest 2013 0.75
100 The role of des-gamma-carboxyprothrombin expression in hepatocellular carcinoma. Hepatogastroenterology 2008 0.75
101 [Aprepitant successful for controlling nausea and vomiting in a case having difficulty with control treatment in a standard antienemic therapy involving chemotherapy for gallbladder cancer postoperative recurrence]. Gan To Kagaku Ryoho 2011 0.75
102 Gene profile in the spleen under massive partial hepatectomy using complementary DNA microarray and pathway analysis. J Gastroenterol Hepatol 2014 0.75
103 Cytokine expression in spleen affects progression of liver cirrhosis through liver-spleen cross-talk. Hepatol Res 2014 0.75
104 New type of artificial liver support system (ALSS) using the photocatalytic effect of titanium oxide. Dig Dis Sci 2007 0.75
105 Detection of Lymph Nodes Metastasis in Biliary Carcinomas: Morphological Criteria by MDCT and the Clinical Impact of DWI-MRI. Hepatogastroenterology 2015 0.75
106 Effective use of a vessel-sealing system for laparoscopic unroofing of liver cysts. Asian J Endosc Surg 2015 0.75
107 The impact of pegylated-interferon α-2b on partial and massive hepatectomy model in rats. Hepatogastroenterology 2012 0.75
108 De novo lung cancer diagnosed 32 months after liver transplantation: report of a case. Surg Today 2011 0.75
109 Impact of a new refrigerator on the preservation of hepatic grafts. Hepatol Res 2012 0.75
110 Optimal administration of tacrolimus in reduced-size liver. Dig Dis Sci 2008 0.75
111 Hilar cholangiocarcinoma accompanied by pancreaticobiliary maljunction without bile duct dilatation 20 years after cholecystectomy: report of a case. J Med Invest 2013 0.75
112 Surgical strategy for advanced gallbladder carcinoma according to invasive depth of the tumor. Hepatogastroenterology 2009 0.75
113 Impact of a new refrigerator for the preservation of whole blood. J Surg Res 2010 0.75
114 Usefulness of artificial endocrine pancreas during resection of insulinoma. J Med Invest 2014 0.75
115 Usefulness of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) in patients for unresectable biliary carcinoma. Hepatogastroenterology 2009 0.75
116 Biliary reconstruction in right lobe living donor liver transplantation. Hepatol Res 2008 0.75